David Pernock's Insider Trades & SAST Disclosures

David Pernock's most recent trade in Eagle Pharmaceuticals Inc was a trade of 9,700 Common Stock done . Disclosure was reported to the exchange on Feb. 2, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eagle Pharmaceuticals Inc
David Pernock Pres & Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2021 9,700 54,625 (0%) 0% 0 Common Stock
Eagle Pharmaceuticals Inc
David Pernock Pres & Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.70 per share. 23 Jan 2021 1,892 44,925 (0%) 0% 47.7 90,248 Common Stock
Eagle Pharmaceuticals Inc
David Pernock Pres & Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.97 per share. 07 Jan 2021 906 46,817 (0%) 0% 51.0 46,179 Common Stock
Eagle Pharmaceuticals Inc
David Pernock Pres & Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.02 per share. 05 Jan 2021 2,088 47,723 (0%) 0% 50.0 104,442 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades